So, @kpax any thoughts on Monepantel vs posterior cortical atrophy? I know that a lot of Alzheimer's patients think it should be classified as a completely different disease because it attacks a different part of the brain, but does it share the characteristics that MPL could potentially address?
The Final Charge , Phase I/II MND Results & FDA ODD Approval Catalyst, page-951
-
- There are more pages in this discussion • 474 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
18.3¢ |
Change
-0.013(6.41%) |
Mkt cap ! $91.16M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 19.0¢ | 18.0¢ | $127.8K | 690.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 319025 | 18.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 18.5¢ | 178178 | 6 |
View Market Depth
| Last trade - 14.54pm 05/08/2024 (20 minute delay) ? |
| PAA (ASX) Chart |